The Truth About Ozempic Pens: Does Ozempic Only Come in a Pen?

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic pens represent one delivery method for semaglutide, a GLP-1 receptor agonist proven to reduce body weight by 5-15% in clinical trials. However, the Ozempic brand is far from the only way to access semaglutide therapy. PlexusDx partners with licensed 503A compounding pharmacies to deliver semaglutide in multiple formats, each designed to fit different patient preferences and lifestyles.

How Ozempic Pens Work and Why They're Popular

Ozempic pens are prefilled injection devices that deliver semaglutide subcutaneously once weekly. The pen format appeals to patients who want simplicity—load, dial the dose, inject, and store until the next week. However, Ozempic's manufacturer-set pricing, insurance restrictions, and supply chain delays have created barriers for many people seeking weight loss treatment.

The pen's convenience comes at a cost. Branded Ozempic typically requires insurance coverage or significant out-of-pocket spending, often exceeding $900 per month without subsidies. Additionally, Ozempic pens are manufactured exclusively in one format, limiting options for patients who may need different delivery methods or who experience injection-site reactions to the brand formulation.

Semaglutide Beyond the Pen: Injection and Oral Alternatives

Semaglutide exists in three distinct delivery forms: branded pens, compounded injections, and oral tablets. Compounded semaglutide injections provide the same active ingredient and weekly dosing schedule as Ozempic pens but are manufactured by licensed 503A compounding pharmacies at a lower cost. PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan)—a significant savings compared to branded alternatives.

Oral semaglutide tablets offer a needle-free option for patients who prefer not to inject. Taken daily rather than weekly, oral formulations allow patients to gradually increase their dose as their body adjusts. PlexusDx Oral Semaglutide is $289/mo month-to-month, or from $249/mo on the 6-month plan and provides the same weight-loss mechanism as injections, with the added benefit of patient choice in administration method. Your dose may need to go up. Your price won't.

Compounded Semaglutide Quality and Safety Standards

Licensed 503A compounding pharmacies operate under strict FDA oversight and USP pharmaceutical standards, ensuring that compounded semaglutide meets rigorous purity, potency, and sterility requirements. These facilities must follow Good Manufacturing Practices (GMP) and undergo regular inspections. Patients receive the same active pharmaceutical ingredient found in Ozempic, manufactured to pharmaceutical-grade standards in a controlled environment.

PlexusDx sources semaglutide exclusively from licensed 503A compounding pharmacies—never from 503B facilities. This distinction matters: 503A compounders prepare patient-specific medications on-demand, while 503B facilities operate under different regulations. By partnering only with 503A compounders, PlexusDx ensures transparency, traceability, and direct accountability for every dose delivered to patients across all 50 states.

Cost Savings and Accessibility: Why PlexusDx Compounded Options Matter

The average monthly cost of branded Ozempic ranges from $800 to $1,200 before insurance, placing weight loss treatment out of reach for millions of Americans. PlexusDx eliminates insurance requirements, membership fees, and approval delays. Compounded Semaglutide Injection at $189/mo (or $149/mo on the 6-month plan) and Oral Semaglutide at $289/mo (or $249/mo on the 6-month plan) represent a 75-80% reduction in cost compared to uninsured Ozempic. Additionally, both are HSA- and FSA-eligible, allowing patients to use pretax dollars.

PlexusDx serves patients in all 50 states with no insurance required and no subscription fees. Patients can upgrade their dosage as their treatment progresses without paying more—a model designed around real clinical needs rather than profit margins. For those seeking personalized insights into their genetic predisposition to GLP-1 response, the Precision Peptide Genetic Test ($298) identifies individual variations in peptide pathways that influence treatment effectiveness.

Choosing Between Injection and Oral Semaglutide

The choice between injection and oral semaglutide depends on individual preferences, injection comfort, and daily routine. Weekly injections require consistency but involve minimal daily effort—patients inject once on the same day each week. Oral tablets demand daily adherence but eliminate needle anxiety for patients with injection phobia. Both methods achieve similar weight-loss outcomes when taken as prescribed, with clinical trials showing comparable effectiveness across delivery routes.

Patients new to semaglutide therapy often benefit from discussing both options with their PlexusDx care team. Some patients start with oral tablets to build confidence and familiarity with the medication, then transition to injections for convenience. Others prefer injections from the start. PlexusDx supports flexibility: your dose may need to go up. Your price won't—whether you're injecting weekly or taking a tablet daily.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide the same as Ozempic?

Yes, compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic. The difference lies in manufacturing location and cost: compounded versions are made by licensed 503A pharmacies rather than a pharmaceutical manufacturer, resulting in significantly lower prices without compromising safety or efficacy. Both are human GLP-1 receptor agonists proven to reduce body weight.

Can I get semaglutide without injections?

Absolutely. PlexusDx Oral Semaglutide is a daily tablet alternative to injections, at $289/mo month-to-month, or from $249/mo on the 6-month plan. Oral semaglutide works through the same mechanism as injections but is absorbed through the digestive tract. Patients take it on an empty stomach each morning, making it an excellent option for those who prefer to avoid needles.

Why is PlexusDx semaglutide so much cheaper than Ozempic?

PlexusDx eliminates insurance intermediaries, removes membership fees, and partners with licensed 503A compounding pharmacies that operate on lower-cost models than pharmaceutical manufacturers. Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan)—accessible nationwide without insurance approval delays. Patients pay directly for what they use, and your dose may need to go up. Your price won't.

Are there side effects with compounded semaglutide?

Compounded semaglutide has the same safety profile as branded versions because the active ingredient is identical. Common side effects include nausea, mild gastrointestinal discomfort, and appetite suppression—typically temporary and decreasing over time. Serious adverse events are rare. PlexusDx patients receive ongoing clinical support to monitor tolerability and adjust doses appropriately.

What does the Precision Peptide Genetic Test reveal about semaglutide response?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.